BI
MRK icon

Boulegeris Investments’s Merck MRK Stock Holding History

Boulegeris Investments’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,105
Closed -$759K – 31
2018
Q2 		$759K Buy
13,105
+1,996
+18% +$113K 0.38% 39
2018
Q1 		$577K Buy
11,109
+396
+4% +$21.4K 0.32% 42
2017
Q4 		$575K Sell
10,713
-1,037
-9% -$57.5K 0.3% 40
2017
Q3 		$718K Buy
11,750
+2,054
+21% +$125K 0.4% 35
2017
Q2 		$593K Buy
9,696
+4,242
+78% +$258K 0.34% 37
2017
Q1 		$331K Buy
+5,454
New +$331K 0.2% 42
2016
Q4 		– Sell
-4,860
Closed -$289K – 50
2016
Q3 		$289K Buy
+4,860
New +$284K 0.18% 43

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boulegeris Investments's MRK Position: Q3 2018 in Review

Boulegeris Investments sold out of Merck (MRK) in Q3 2018, closing a stake of 13,105 shares — an estimated $759K sold.

Boulegeris Investments first reported a position in MRK in Q3 2016 and held it in 7 quarters. The position peaked at $759K in Q2 2018. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Boulegeris Investments reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Boulegeris Investments sold 13,105 Merck shares in Q3 2018, an estimated $759K.
  • Boulegeris Investments first reported a position in Merck in Q3 2016 and held it in 7 quarters.
  • Boulegeris Investments's Merck position peaked at $759K in Q2 2018.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Boulegeris Investments's 13F filing for Q3 2018.